PSY23 AGALSIDASE ALFA AND AGALSIDASE BETA FOR TREATMENT OF FABRY DISEASE

dc.contributor.authorCosta, MGS
dc.contributor.authorSantos, M
dc.contributor.authorSenna, K
dc.date.accessioned2024-10-29T17:01:47Z
dc.date.available2024-10-29T17:01:47Z
dc.date.issued2018
dc.identifier.citationCosta MGS, Santos M, Senna K. PSY23 AGALSIDASE ALFA AND AGALSIDASE BETA FOR TREATMENT OF FABRY DISEASE. VALUE IN HEALTH. 2018 oct;21(S1)eS481. doi: 10.1016/j.jval.2018.09.2600
dc.identifier.otherDOI: 10.1016/j.jval.2018.09.2600
dc.identifier.urihttps://dspace.inc.saude.gov.br/handle/123456789/545
dc.language.isoen
dc.publisherVALUE IN HEALTH
dc.titlePSY23 AGALSIDASE ALFA AND AGALSIDASE BETA FOR TREATMENT OF FABRY DISEASE
dc.typeArticle
Arquivos
Original bundle
Agora exibindo 1 - 1 de 1
thumbnail.default.alt
Nome:
Costa MG et al_Value Health.pdf
Tamanho:
773.42 KB
Formato:
Adobe Portable Document Format
Descrição:
License bundle
Agora exibindo 1 - 1 de 1
thumbnail.default.placeholder
Nome:
license.txt
Tamanho:
1.71 KB
Formato:
Item-specific license agreed to upon submission
Descrição: